ROCHE HOLDING LTD S/ADR by Roche Holding Ltd Market Sentiment

ROCHE HOLDING LTD S/ADR by Roche Holding Ltd

RHHBYOTCQX

Trade with Public

$55.19

-1.20-2.13%

가까이에: Aug 28, 5:00 PM EST

$55.21

0.020.04%

시간외: 4:02 PM EST

개요 뉴스 목표가 재무심리지분 현황 비교

ROCHE HOLDING LTD S/ADR by Roche Holding Ltd Market Sentiment

Market sentiment signals for ROCHE HOLDING LTD S/ADR by Roche Holding Ltd (RHHBY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Market Perform

Short Interest— N/A

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Market Perform

1 analysts

Options Flow (P/C)

—

Avg Consensus PT

$40

-27.5%

Highest Price Target

$40

-27.5%

TD Cowen

Lowest Price Target

$40

-27.5%

TD Cowen

Short Interest

—

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 12, 2023	TD Cowen	Steve Scala—	-27.5%	$45 → $40	Maintained	Market Perform

Insider & Market Activity News

Options Corner: Bullish Traders Eye Eli Lilly As Market Signals Hint At A Turnaround

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY stock.

Josh Enomoto

Two Biotech Stocks Poised For Big Moves On Monday

David Pinsen

The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Novartis, Roche Agreed on Bilateral Transaction for the Sale of Roche Bearer Shares Held by Novartis for $20.7B

Novartis has agreed to sell 53.3 million (approximately 33%) Roche bearer shares in a bilateral transaction to Roche for a total consideration of USD 20.7 billion.

Charles Gross

These Were The Most Active Securities On OTC Markets In October

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Dollar trading volume on OTC Markets topped $29 billion in October, approximately a 4.5% increase from September.

Spencer Israel

Novartis Decides Not Sell 33% Roche Stake -HandelsZeitung

Benzinga

ROCHE HOLDING LTD S/ADR by Roche Holding Ltd

ROCHE HOLDING LTD S/ADR by Roche Holding Ltd Market Sentiment

Key Signals

Recent Analyst Actions

Insider & Market Activity News

Options Corner: Bullish Traders Eye Eli Lilly As Market Signals Hint At A Turnaround

Two Biotech Stocks Poised For Big Moves On Monday

The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK

Novartis, Roche Agreed on Bilateral Transaction for the Sale of Roche Bearer Shares Held by Novartis for $20.7B

These Were The Most Active Securities On OTC Markets In October

Novartis Decides Not Sell 33% Roche Stake -HandelsZeitung

뉴스

파트너 / 기고자

벤징가 글로벌